Fusion IP, which commercialises university research, has announced that Certara, a leading provider of drug discovery and development software and scientific consulting services, has agreed to acquire Fusion's portfolio company, Simcyp.
The $32m purchase moves Simcyp into the Certara portfolio and further supports Certara's emphasis on supporting translational science initiatives.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Public stock markets are shrinking: where could investors turn for growth?Royal Mail, Darktrace, Skechers – more and more companies are being taken private. But investors needn’t miss out. Investing in private companies is no longer off-limits – and you can invest from just £10,000.
-
Is property investment still as safe as houses? Why golden era could be overThe golden era of property is over and investors are better off in the stock market, new research suggests
